Livsmed Inc (KOSDAQ:491000)

South Korea · Delayed Price · Currency is KRW

46,400

-3,500 (-7.01%)

At close: Aug 11, 2026

Livsmed Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	51,725	51,192	27,121	17,267	9,678
Revenue Growth	61.66%	88.75%	57.07%	78.42%	-
Gross Profit	28,047	29,534	14,547	9,479	5,477
Operating Income	-24,352	-22,642	-26,504	-23,912	-17,090
Net Income	-22,459	-22,874	-25,585	-57,021	-59,019
Earnings Per Share	-979.51	-1030.07	-1530.99	-4024.24	-4597.99
EPS Growth	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
South Korea	46,758	45,684	23,431	14,192	8,059
USA	2,510	3,067	2,110	1,691	705.8
Germany	1,034	962.26	740.63	507.51	368.47
Other	1,421	1,479	839.86	876.63	544.47
Total	51,725	51,192	27,121	17,267	9,678

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	116,458	131,402	16,815	40,019	14,911
Total Debt	12,302	11,607	8,479	5,214	7,225
Net Cash (Debt)	104,156	119,795	8,336	34,804	7,686
Net Cash Growth	1149.40%	1337.00%	-76.05%	352.82%	-
Net Cash Per Share	4542.67	5394.74	498.85	2456.31	598.79

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	-38,587	-34,740	-27,664	-24,723	-17,881
Capital Expenditures	-7,564	-7,233	-4,345	-2,298	-654.24
Free Cash Flow	-46,151	-41,973	-32,009	-27,020	-18,535
Free Cash Flow Growth	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	54.22%	57.69%	53.64%	54.90%	56.59%
Operating Margin	-47.08%	-44.23%	-97.72%	-138.48%	-176.59%
Pretax Margin	-43.42%	-44.68%	-94.33%	-330.23%	-609.85%
Profit Margin	-43.42%	-44.68%	-94.34%	-330.23%	-609.85%
FCF Margin	-89.22%	-81.99%	-118.02%	-156.49%	-191.52%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
PS Ratio	21.61	24.93	-	-	-